• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Med Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy

tetano

Editor, Senior Moderator
J Clin Med


. 2020 May 20;9(5):E1548.
doi: 10.3390/jcm9051548.
Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy


Maurizio Cecconi[SUP] 1 2 [/SUP], Daniele Piovani[SUP] 1 2 [/SUP], Enrico Brunetta[SUP] 1 2 [/SUP], Alessio Aghemo[SUP] 1 2 [/SUP], Massimiliano Greco[SUP] 1 2 [/SUP], Michele Ciccarelli[SUP] 1 2 [/SUP], Claudio Angelini[SUP] 1 2 [/SUP], Antonio Voza[SUP] 1 2 [/SUP], Paolo Omodei[SUP] 1 2 [/SUP], Edoardo Vespa[SUP] 1 2 [/SUP], Nicola Pugliese[SUP] 1 2 [/SUP], Tommaso Lorenzo Parigi[SUP] 1 2 [/SUP], Marco Folci[SUP] 1 2 [/SUP], Silvio Danese[SUP] 1 2 [/SUP], Stefanos Bonovas[SUP] 1 2 [/SUP]



Affiliations

Abstract

We described features of hospitalized Covid-19 patients and identified predictors of clinical deterioration. We included patients consecutively admitted at Humanitas Research Hospital (Rozzano, Milan, Italy); retrospectively extracted demographic; clinical; laboratory and imaging findings at admission; used survival methods to identify factors associated with clinical deterioration (defined as intensive care unit (ICU) transfer or death), and developed a prognostic index. Overall; we analyzed 239 patients (29.3% females) with a mean age of 63.9 (standard deviation [SD]; 14.0) years. Clinical deterioration occurred in 70 patients (29.3%), including 41 (17.2%) ICU transfers and 36 (15.1%) deaths. The most common symptoms and signs at admission were cough (77.8%) and elevated respiratory rate (34.1%), while 66.5% of patients had at least one coexisting medical condition. Imaging frequently revealed ground-glass opacity (68.9%) and consolidation (23.8%). Age; increased respiratory rate; abnormal blood gas parameters and imaging findings; coexisting coronary heart disease; leukocytosis; lymphocytopenia; and several laboratory parameters (elevated procalcitonin; interleukin-6; serum ferritin; C-reactive protein; aspartate aminotransferase; lactate dehydrogenase; creatinine; fibrinogen; troponin-I; and D-dimer) were significant predictors of clinical deterioration. We suggested a prognostic index to assist risk-stratification (C-statistic; 0.845; 95% CI; 0.802‒0.887). These results could aid early identification and management of patients at risk, who should therefore receive additional monitoring and aggressive supportive care.

Keywords: 2019 novel coronavirus; 2019-nCoV; COVID-19; SARS-CoV-2; severe acute respiratory syndrome coronavirus 2.
 
Back
Top Bottom